# Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB.

> PubMed lists PMID 41987916 in JIMD reports as Journal Article, with publication-date metadata of 2026-04-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41987916-teriparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-13
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41987916-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41987916-teriparatide-v1.json
- Content SHA-256: `e24791129fc44f690bd89f3063245d721d2862f88b4e5a290414e472b3f7f3d4`

## Claims and source pins

### Headline

Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB. ([`pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355`](#source-pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355))

### Summary

PubMed lists PMID 41987916 in JIMD reports as Journal Article, with publication-date metadata of 2026-04-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355`](#source-pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355))

### Paragraph 1

PubMed lists PMID 41987916 in JIMD reports as Journal Article, with publication-date metadata of 2026-04-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355`](#source-pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355`](#source-pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355))

## Sources

<a id="source-pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355"></a>
- **Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB. · retained source version 1:2026-08-13:current:8f7a6b5d5355ee9550f5bfbc0ea2400cfcf5d942402e5b481a5b34c92598d092** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41987916/) (`pubmed-observation-pmid-41987916-2026-08-13-8f7a6b5d5355`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41987916-teriparatide-v1.json SHA-256: e24791129fc44f690bd89f3063245d721d2862f88b4e5a290414e472b3f7f3d4.